AKI was detected in 45 (34.6%) patients, mainly stage 1 - in 42 (93.3%). At the time of admission to the hospital for stroke, 58 patients (44.6%) had CKD. CKD-related AKI was detected in 21 patients (16,2%). Prehospital AKI was established in 29 (64.4%), hospital AKI - in 16 patients (35.5%). A decrease in eGFR ≤ 60 mL/min/1.73 m2 had 66 patients (50.8%) in the rehabilitation department. High levels of proinflammatory IL-6, IL-8, IL-18, VEGF and MCP-1, low levels of anti-inflammatory IL-10 and erythropoietin were detected in older patients after CVA with renal dysfunction (p <0.05) (Table 1,2)
Parameter N=96, Me (IQR)
IL-6 (Me (IQR), pg/ml 2,7 (2,1;4,8)
IL-8 (Me (IQR), pg/ml 9,5 (5,7;18,9)
IL-10 (Me (IQR), pg/ml 1,5 (0,2;6,8)
IL-18 (Me (IQR), pg/ml 106,9 (59,4;210,5)
MCP1 (Me (IQR), pg/ml 329,8 (149,5;465,3)
VEGF (Me (IQR), pg/ml 200,2 (126,1;323,9)
Erythropoetin (Me (IQR), mME/ml 11,5 (7,6;16,9)
Table 1. Proinflammatory profile of patients serum
Parameter N=96, Me (IQR)
IL-6 (Me (IQR), pg/ml 3,5 (1,0;10,7)
IL-8 (Me (IQR), pg/ml 1,9 (0,0;10,9)
IL-10 (Me (IQR), pg/ml 0,0 (0,0;1,1)
IL-18 (Me (IQR), pg/ml 0,1 (0,0;6,22)
MCP1 (Me (IQR), pg/ml 61,3 (5,9;216,2)
VEGF (Me (IQR), pg/ml 46,6 (12,3;182,5)
Table 2. Proinflammatory profile of patients urine